Stock Research: Ono Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ono Pharmaceutical

TYO:4528 JP3197600004
92
  • Value
    92
  • Growth
    78
  • Safety
    Safety
    66
  • Combined
    92
  • Sentiment
    65
  • 360° View
    360° View
    92
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company that manufactures and sells pharmaceuticals. The company operates in the pharmaceutical industry. ONO PHARMACEUTICAL CO., LTD. operates primarily in Japan. In the last fiscal year, the company had a market cap of $5,561 million, profits of $2,260 million, revenue of $3,247 million, and 4287 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 94 84 65
Growth
78 22 11 57
Safety
Safety
66 95 90 82
Sentiment
65 6 32 31
360° View
360° View
92 61 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
1 1 5 41
Opinions Change
87 35 50 40
Pro Holdings
n/a 10 70 82
Market Pulse
50 46 44 12
Sentiment
65 6 32 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 94 84 65
Growth
78 22 11 57
Safety Safety
66 95 90 82
Combined
92 89 75 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
44 69 41 39
Price vs. Earnings (P/E)
60 88 100 89
Price vs. Book (P/B)
77 88 62 61
Dividend Yield
97 91 89 77
Value
92 94 84 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
20 41 10 76
Profit Growth
32 4 54 52
Capital Growth
100 79 32 17
Stock Returns
82 8 19 55
Growth
78 22 11 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
74 83 85 80
Refinancing
29 73 51 39
Liquidity
72 97 98 96
Safety Safety
66 95 90 82

Similar Stocks

Discover high‑ranked alternatives to Ono Pharmaceutical and broaden your portfolio horizons.

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Brother Industries

TYO:6448
Country: Japan
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Shikoku Electric Power

TYO:9507
Country: Japan
Industry: Electric Utilities
Size: Large
Full Stock Analysis

transcosmos

TYO:9715
Country: Japan
Industry: Diversified Support Services
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: